TrialCirculation2009

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

Rutger W van der Meer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.